Genentech Xolair Covered Under Patent License, PDL Says; Seeks Royalties
Executive Summary
Protein Design Labs is seeking lower-level staff discussions with Genentech to determine whether the humanized anti-IgE antibody Xolair requires a license under PDL's antibody humanization patents